Skip to content
Assyro AI
FDA Orange Book ยท active-ingredient family

Busulfan

Busulfan: 2 brands, 15 generics; first approved Feb 04, 1999; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 15 ANDA applications approved.

Brands (NDA)
2
Generics (ANDA)
15
Listed patents
0
Presentations
17

Brand (NDA) products

Originator applications
Ask AI
  • NDA 0209541999
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • MYLERANRLDRS
    NDA 009386-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    2MGTABLETORALRx-

Generic (ANDA) products (15)

Abbreviated applications
Ask AI
  • BUSULFAN
    ANDA 2152352024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2151022024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2121272020
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2104482019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2109312019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2101482019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2077942019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2051062018
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2056722018
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2051842018
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2095802017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2051392017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2085362017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-
  • BUSULFAN
    ANDA 2070502017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONRxAP
  • BUSULFAN
    ANDA 2022592015
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    6MG/MLINJECTABLEINJECTIONDiscontinued-

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
28 yr 2 mo ago
Most recent approval
2 yr 3 mo ago

Approvals span 1999โ€“2024 across 17 FDA applications.

Brand (NDA) 212%
Generic (ANDA) 1588%

Busulfan: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Busulfan

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo